Liver Disease in α1-Antitrypsin Deficiency
- 1 January 2016
- book chapter
- Published by Springer Nature
- p. 111-140
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiencyEMBO Molecular Medicine, 2013
- Cytoplasmic STAT3 Represses Autophagy by Inhibiting PKR ActivityMolecular Cell, 2012
- Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA ProfilesMolecular Therapy, 2012
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- Design and Validation of the Biliary Atresia Research Consortium Histologic Assessment System for Cholestasis in InfancyClinical Gastroenterology and Hepatology, 2011
- Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in MiceCell, 2009
- Substrate-specific mediators of ER associated degradation (ERAD)Current Opinion in Cell Biology, 2009
- Single nucleotide polymorphism–mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency #Hepatology, 2009
- Small Molecules Block the Polymerization of Z α1-Antitrypsin and Increase the Clearance of Intracellular AggregatesJournal of Medicinal Chemistry, 2007
- Small molecules enhance autophagy and reduce toxicity in Huntington's disease modelsNature Chemical Biology, 2007